Semaglutide is gaining traction as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to produce more insulin and reducing https://finniandpbb391216.nizarblog.com/35868945/comprehending-semaglutide-a-comprehensive-guide